These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 27072506)

  • 41. One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces.
    Huang H; Zheng G; Jiang W; Hu H; Lu Y
    Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):231-43. PubMed ID: 25739462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Challenges of in vitro genome editing with CRISPR/Cas9 and possible solutions: A review.
    Ebrahimi V; Hashemi A
    Gene; 2020 Aug; 753():144813. PubMed ID: 32470504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
    Zhu Z; González F; Huangfu D
    Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRISPRi engineering E. coli for morphology diversification.
    Elhadi D; Lv L; Jiang XR; Wu H; Chen GQ
    Metab Eng; 2016 Nov; 38():358-369. PubMed ID: 27693319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRISPRi/dCpf1-mediated dynamic metabolic switch to enhance butenoic acid production in Escherichia coli.
    Ji X; Zhao H; Zhu H; Zhu K; Tang SY; Lou C
    Appl Microbiol Biotechnol; 2020 Jun; 104(12):5385-5393. PubMed ID: 32338294
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleic Acid-Dependent Conformational Changes in CRISPR-Cas9 Revealed by Site-Directed Spin Labeling.
    Vazquez Reyes C; Tangprasertchai NS; Yogesha SD; Nguyen RH; Zhang X; Rajan R; Qin PZ
    Cell Biochem Biophys; 2017 Jun; 75(2):203-210. PubMed ID: 27342128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Novel and Efficient Genome Editing Tool Assisted by CRISPR-Cas12a/Cpf1 for
    Zhang X; Gu S; Zheng X; Peng S; Li Y; Lin Y; Liang S
    ACS Synth Biol; 2021 Nov; 10(11):2927-2937. PubMed ID: 34644057
    [No Abstract]   [Full Text] [Related]  

  • 48. CRISPR-Cas9-assisted native end-joining editing offers a simple strategy for efficient genetic engineering in Escherichia coli.
    Huang C; Ding T; Wang J; Wang X; Guo L; Wang J; Zhu L; Bi C; Zhang X; Ma X; Huo YX
    Appl Microbiol Biotechnol; 2019 Oct; 103(20):8497-8509. PubMed ID: 31501938
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DEVELOPMENT. CRISPR views of embryos and cells.
    Kupferschmidt K
    Science; 2016 Jun; 352(6290):1156-7. PubMed ID: 27257236
    [No Abstract]   [Full Text] [Related]  

  • 50. CRISPR-Cpf1-Assisted Multiplex Genome Editing and Transcriptional Repression in Streptomyces.
    Li L; Wei K; Zheng G; Liu X; Chen S; Jiang W; Lu Y
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980561
    [No Abstract]   [Full Text] [Related]  

  • 51. Generation of a conditional analog-sensitive kinase in human cells using CRISPR/Cas9-mediated genome engineering.
    Moyer TC; Holland AJ
    Methods Cell Biol; 2015; 129():19-36. PubMed ID: 26175431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fusion guide RNAs for orthogonal gene manipulation with Cas9 and Cpf1.
    Kweon J; Jang AH; Kim DE; Yang JW; Yoon M; Rim Shin H; Kim JS; Kim Y
    Nat Commun; 2017 Nov; 8(1):1723. PubMed ID: 29167440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CRISPR/Cas9 in Genome Editing and Beyond.
    Wang H; La Russa M; Qi LS
    Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR-PCS: a powerful new approach to inducing multiple chromosome splitting in Saccharomyces cerevisiae.
    Sasano Y; Nagasawa K; Kaboli S; Sugiyama M; Harashima S
    Sci Rep; 2016 Aug; 6():30278. PubMed ID: 27530680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Standardized Markerless Gene Integration for Pathway Engineering in Yarrowia lipolytica.
    Schwartz C; Shabbir-Hussain M; Frogue K; Blenner M; Wheeldon I
    ACS Synth Biol; 2017 Mar; 6(3):402-409. PubMed ID: 27989123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional interrogation of non-coding DNA through CRISPR genome editing.
    Canver MC; Bauer DE; Orkin SH
    Methods; 2017 May; 121-122():118-129. PubMed ID: 28288828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RNA-guided editing of bacterial genomes using CRISPR-Cas systems.
    Jiang W; Bikard D; Cox D; Zhang F; Marraffini LA
    Nat Biotechnol; 2013 Mar; 31(3):233-9. PubMed ID: 23360965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Guide RNA engineering for versatile Cas9 functionality.
    Nowak CM; Lawson S; Zerez M; Bleris L
    Nucleic Acids Res; 2016 Nov; 44(20):9555-9564. PubMed ID: 27733506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Easy regulation of metabolic flux in Escherichia coli using an endogenous type I-E CRISPR-Cas system.
    Chang Y; Su T; Qi Q; Liang Q
    Microb Cell Fact; 2016 Nov; 15(1):195. PubMed ID: 27842593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.